Australia is an acknowledged world leader in the MTP sector due to its thriving research environment and industry.
The National Health and Medical Research Council (NHMRC) reports that Australia contributes c.3% of the world's trusted biomedical research; ranked fifth in innovation in the 2016 Scientific American Worldview; and between 2001 and 2010, Australia ranked sixth in the world in terms of overall output of health and medical publications
Research institutes in Australia include universities, medical research institutes, Cooperative Research Centres, CSIRO, incubators, and hospitals, working through basic research, to preclinical research and development, and clinical development.
In this section, Australian research institutes, researchers and students can find out more about connecting with infrastructure and funding to aid their research in the medtech, biotech and pharmaceuticals sector.
A collaboration between the CSIRO and Australian dental company Oventus has developed a game changing solution for people suffering from sleep apnoea.
Monash University Faculty of Medicine, Nursing and Health Sciences was the first Australian academic research institute to be invited by Pfizer to join their Centers for Therapeutic Innovation
Amgen Australia conducts on average two ‘first in human’ studies every year, with almost half of their clinical trial research being early phase.
Ms Sue MacLeman, Managing Director and CEO MTPConnect will present on Australia's medtech capabilities and competitive advantages at a medtech Showcase in Seoul.
Wednesday, 10 August 2016, Canberra, Australia--MTPConnect and ARCS Australia have signed a Memorandum of Understanding (MoU), agreeing to work closely together for the benefit of the MedTech, biotechnology and pharmaceutical industry.